SCHEMBL3344060

SCHEMBL3344060

OC1C=Cc2cc3ccc4cccc5ccc(c2C1O)c3c45

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.41
ERBB2 P04626 1/20 0.41
FYN P06241 1/20 0.41
MAOA P21397 1/20 0.41
ACHE P22303 1/20 0.41
AHR P35869 1/20 0.41
ALDH1A1 P00352 5/20 0.40
HPGD P15428 5/20 0.40
HSD17B10 Q99714 4/20 0.40
CYP3A4 P08684 2/20 0.40
TSHR P16473 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 3/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
CYP1A1 P04798 2/20 0.33
CYP1B1 Q16678 2/20 0.33
THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3343813 0.76 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL3343814 0.76 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL6670237 0.76 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL6735412 0.76 CYP1A2 (0.41) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL637370 0.72 KDM4E (0.38) CYP1A2ALDH1A1HSD17B10TSHRTDP1
SCHEMBL637369 0.72 KDM4E (0.38) CYP1A2ALDH1A1HSD17B10TSHRTDP1
SCHEMBL29730876 0.70 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL2041215 0.70 CYP1A2 (0.44) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL20827638 0.67 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL14412206 0.67 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052418-A1 METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-02-15 US disclosed
US-11814681-B2 Method for predicting a subjects response to SLC modulator therapy THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-11-14 US disclosed
US-20210254158-A1 METHOD FOR PREDICTING A SUBJECTS RESPONSE TO SLC MODULATOR THERAPY RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC. 2021-08-19 US disclosed
WO-2019046303-A1 A METHOD FOR PREDICTING A SUBJECT'S RESPONSE TO SLC MODULATOR THERAPY THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-03-07 WO disclosed
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 WO disclosed
US-6204049-B1 COMPOSITION FOR DETOXIFICATION OF POLLUTED FLUIDS; FOR POLLUTION CONTROL THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 2001-03-20 US disclosed